Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-07 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −22,151 $35.29 $782K 223,901
2023-03-07 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −5,538 $35.29 $195K 86,300
2023-03-07 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) −22,151 1,074,364
2023-03-06 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +32,000 $3.95 $126K 255,901
2023-03-06 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −32,000 $35.81 $1.1M 223,901
2023-03-06 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −8,000 $35.81 $286K 91,838
2023-03-06 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) −32,000 1,096,515
2023-03-03 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +32,000 $3.95 $126K 255,901
2023-03-03 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −32,000 $36.25 $1.2M 223,901
2023-03-03 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −8,000 $36.26 $290K 99,838
2023-03-03 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) −32,000 1,128,515
2023-03-03 Schlanger David J Executive Chairman Exercise or conversion +41,666 $0.91 $38K 117,834
2023-03-03 Schlanger David J Executive Chairman Sale −41,666 $36.26 $1.5M 76,168
2023-03-03 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) −41,666 732,228
2023-03-02 Livingston Mark S. CHIEF FINANCIAL OFFICER Grant or award +7,000 63,949
2023-03-02 Livingston Mark S. CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +20,000 20,000
2023-03-02 Sturmer Michael E PRESIDENT Grant or award +7,000 210,881
2023-03-02 Sturmer Michael E PRESIDENT Grant or award · Stock Option (Right to Buy) +20,000 20,000
2023-03-02 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +32,000 $3.95 $126K 255,901
2023-03-02 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −25,758 $35.97 $927K 230,143

Page 28 of 77 · 1,524 trades